Comparison of P-Wave Duration and Dispersion in Mitral Valve Replacement Surgery Via Right Atrial Transseptal or Left Atrial Approach in Rheumatic Mitral Stenosis Patients
Keywords:Arrhythmias, cardiac; mitral valve stenosis; heart valve prosthesis; electrocardiography
Background: Predisposition to atrial fibrillation in mitral valve surgery has been well demonstrated. The changes in electrocardiographic parameters (Pmax, Pmin and P-wave dispersion) related to AF risk are unknown. We aimed to document the relationship between electrocardiographic changes and mitral valve replacement through right or left atrial surgical approaches.
Methods: We retrospectively studied 154 patients, who underwent mitral valve replacement surgery from 2008 to 2018. Seventy-nine patients were operated with right atriotomy and transseptal approach (Group 1), and 75 patents were operated with left atriotomy (Group 2). ECGs obtained at hospital admittance and postoperatively at 24 hours were blindly analyzed.
Results: Preoperative demographic characteristics were similar. Pmax, Pmin and P-wave dispersion were similar preoperatively. All parameters increased in both groups compared with the preoperative values (P < .05). Postoperative Pmax, Pmin and P-wave dispersion all were statistically significantly higher with the right atrial approach (P < .05). Postoperative AF also was more common in Group 1 (P < .05).
Conclusion: Right atrial approach may lead to higher P-wave changes and atrial arrhythmias. This may be due to more extensive surgical disruption. The changes in atrial anatomic structure can increase atrial arrhythmic propensity and can cause atrial fibrillation.
Aytemir K, Ozer N, Atalar E, Sade E, Aksöyek S et al. 2000. P wave dispersion on 12-lead electrocardiography in patients with paroxysmal atrial fibrillation. Pacing Clin Electrophysiol 23: 1109-12.
Demirkan B, Guray Y, Guray U, Ege MR, Kisacik HL et al. 2013. The acute effect of percutaneous mitral balloon valvuloplasty on atrial electromechanical delay and p-wave dispersion in patients with mitral stenosis. Herz. 38:210-5.
Durukan AB, Gurbuz HA, Unal EU, Tavlasoglu M, Durukan E et al. 2014. Role of neutrophil/lymphocyte ratio in assessing the risk of postoperative atrial fibrillation. J Cardiovasc Surg (Torino) 55:287-93.
Gaudino M, Alessandrini F, Glieca F, Martinelli L, Santarelli P et al. 1997. Conventional left atrial versus superior septal approach for mitral valve replacement. Ann Thorac Surg 63:1123-7.
Iung B, Leenhardt A, Extramiana F. 2018. Management of atrial fibrillation in patients with rheumatic mitral stenosis. Heart 104:1062-8.
Kazemi B, Rostami A, Aslanabadi N, Ghaffari S. 2014. Electrocardiographic p-wave indices as a useful tool to predict successful percutaneous balloon mitral valvotomy in patients with mitral stenosis. J Cardiovasc Thorac Res 6:9-14.
Lomivorotov VV, Efremov SM, Pokushalov EA, Karaskov AM. 2016. New onset atrial fibrillation after cardiac surgery: pathophysiology, prophylaxis and treatment. J Cardiothorac Vasc Anesth. 30:200-16.
Magnani JW, Mazzini MJ, Sullivan LM, Williamson M, Ellinor PT et al. 2010. p-wave indices, distribution and quality control assessment (from the Framingham Heart Study). Ann Noninvasive Electrocardiol 15:77-84.
Mehta CK, McCarthy PM, Andrei AC, Kruse J, Shi H et al. 2018. De novo atrial fibrillation after mitral valve surgery. J Thorac Cardiovasc Surg 156:1515-25.
Mutjaba SS, Clark SC. 2018. Extended trans-septal versus left atrial approach in mitral valve surgery: 1017 patients' experience. Heart Asia. 10:e011008.
Nienaber JJ, Glower DD. 2006. Minitransseptal versus left atrial approach to the mitral valve: a comparison of outcomes. Ann Thorac Surg 82:834-9.
Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd et al. 2017. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. Circulation. 135:e1159-95.
O'Brien B, Burrage PS, Ngai JY, Prutkin JM, Huang CC et al. 2019. Society of Cardiovascular Anesthesiologists/European Association of Cardiothoracic Anaesthetists practice advisory for the management of perioperative atrial fibrillation in patients undergoing cardiac surgery. J Cardiothorac Vasc Anesth 33:12-26.
Okutucu S, Aytemir K, Oto A. 2016. P-wave dispersion: What we know till now? JRSM Cardiovasc Dis 5:2048004016639443.
Rezahosseini O, Rezaei M, Ahmadi Tafti SH, Jalali A, Bina P et al. 2015. Transseptal approach versus left atrial approach to mitral valve: a propensity score matching study. J Tehran Heart Cent 10:188-93.
Takenaka K, Ogawa E, Wada H, Hirata T. 2006. Systemic inflammatory response syndrome and surgical stress in thoracic surgery. J Crit Care 21:48-53.
Toutouzas K, Synetos A, Drakopoulou M, Stefanadi E, Tousoulis D et al. 2009. The role of inflammation in atrial fibrillation: a myth or a fact? Am J Med Scis 338:494-499.
Van Wagoner DR, Chung MK. 2018. Inflammation, Inflammasome activation, and atrial fibrillation. Circulation 138:2243-6.
Wong T, Davlouros PA, Li W, Millington-Sanders C et al. 2004. Mechano-electrical interaction late after fontan operation; relation between p-wave duration and dispersion, right atrial size, and atrial arrhythmias. Circulation 109:2319-25.
How to Cite
Author Disclosure & Copyright Transfer Agreement
In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.
A current form follows:
The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.
However, Publisher grants back to the author(s) the following:
- The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
- The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
- The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
- The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
- The right to make oral presentations of material from this work.
Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.
I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.
I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).
I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.
Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).